Tue, 22 January 2019
In this episode, we review some of the most important new recommendations from the 2018 ACC/AHA guidelines for the management of blood cholesterol. |
Tue, 1 January 2019
In this episode, we will review the FDA’s Unapproved Drugs Initiative and how it has impacted the availability and pricing of commonly used (but old) medications, such as colchicine and vasopressin. |
